TY  - JOUR 
T1  - Is asciminib an effective tyrosine kinase inhibitor for chronic myeloid leukemia patients with tyrosine kinase inhibitor resistance?
JO  - Hematology, Transfusion and Cell Therapy
A1  - Omar, Musab MA
A1  - Alanazi, Majed A
A1  - Jackson, Denise E.
SN  - 2531-1379
UL  - 10.1016/j.htct.2026.106257
VL  - 48 
Y1  - 2026
PB  - Brasil 
ER  -